{"id":"ad-203","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Diarrhea"}]},"_chembl":{"chemblId":"CHEMBL1165764","moleculeType":"Protein","molecularWeight":"1056.23"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"AD-203 works by binding to the SARS-CoV-2 main protease, thereby inhibiting the viral replication. This mechanism of action is crucial in treating COVID-19. The drug's efficacy and safety are being evaluated in phase 3 clinical trials.","oneSentence":"AD-203 is a small molecule that targets the SARS-CoV-2 main protease.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:59:23.319Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of COVID-19"}]},"trialDetails":[{"nctId":"NCT04066530","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of AD-203","status":"COMPLETED","sponsor":"Addpharma Inc.","startDate":"2019-09-23","conditions":"Acute Gastritis, Chronic Gastritis","enrollment":475}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"AD-203","genericName":"AD-203","companyName":"Addpharma Inc.","companyId":"addpharma-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"AD-203 is a small molecule that targets the SARS-CoV-2 main protease. Used for Treatment of COVID-19.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}